Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Reports Surging Q4 Revenue Amid Increased Net Loss

NEW YORK, Feb. 25 (GenomeWeb News) - CombiMatrix reported yesterday that fourth-quarter revenues surged by around $470,000, but that net loss increased by almost half, the company said.

 

Mulkiteo, Wash.-based CombiMatrix had $522,000 in total revenues for fourth quarter, compared to revenues of  $53,000 for the same quarter last year, while increasing its net loss 44 percent to $1.6 million from $1.1 million in the year-ago period.

 

The life-sciences unit of Acacia Research had research and development expenses of $1.4 million for the quarter, down 27 percent from $1.9 million in the fourth quarter of 2003.

 

CombiMatrix said it had around $23.7 million in cash, equivalents, and short-term investments as of Dec. 31, 2004.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.